NCT04383678View on ClinicalTrials.gov

Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome

CompletedOBSERVATIONAL
Enrollment

132

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

April 1, 2021

Study Completion Date

April 1, 2021

Conditions
COVID-19Extracorporeal Membrane Oxygenation ComplicationAcute Respiratory Distress Syndrome
Interventions
DEVICE

Extracorporeal membrane oxygenation

Veno-venous or veno-arterial extracorporeal oxygenation

Trial Locations (11)

Unknown

Helsinki University Hospital, Helsinki

University Hospital Jean Minjoz, Besançon

Nancy University Hospital, Nancy

Henri Mondon Unoversity Hospital, Paris

Robert Debré University Hospital, Reims

Hamburg University Heart Center, Hamburg

Münster University Hospital, Münster

S. Orsola Hospital, Bologna

Lecco Hospital, Lecco

Karolinska University Hospital, Stockholm

University Hospitals of Leicester, Leicester

All Listed Sponsors
lead

Helsinki University Central Hospital

OTHER

NCT04383678 - Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome | Biotech Hunter | Biotech Hunter